References
- Chien Y. W. Novel Drug Delivery Systems2nd Ed. Marcel Dekker, New York 1992
- Ravi Kumar M. N.V., Kumar N. Polymeric controlled drug‐delivery systems: perspectives issues and opportunities. Drug Dev. Ind. Pharm. 2001; 27(1)1–30
- Hsieh D. S., Rhine W., Langer R. Zero‐order controlled‐release polymer matrices and macromolecules. J. Pharm. Sci. 1983; 72: 17–22
- Colombo P. Swelling‐controlled release in hydrogel matrices for oral route. Adv. Drug Deliv. Rev. 1993; 11: 37–57
- Vazquez M. J., Perez‐Marcos B., Gomez‐Amoza J. L., Martinez‐Pacheco R., Souto C., Concheiro A. Influence of technological variables on release of drugs from hydrophilic matrices. Drug Dev. Ind. Pharm. 1992; 18: 1355–1375
- Veiga F., Salsa T., Pina M. E. Oral controlled release dosage forms. II. Glassy polymers in hydrophilic matrices. Drug Dev. Ind. Pharm. 1998; 24(1)1–9
- Sung K. C., Nixon P. R., Skoug J. W., Ju T. R., Gao P., Topp E. M., Patel M. V. Effect of formulation variables on drug and polymer release from HPMC‐base matrix tablets. Int. J. Pharm. 1996; 142: 53–60
- Siepmann J., Kranz H., Bodmeier R., Peppas N. A. HPMC‐matrices for controlled drug delivery: a new model combining diffusion, swelling, and dissolution mechanisms and predicting the release kinetics. Pharm. Res. 1999; 16(11)1748–1756
- Singla M., Chawla A., Singh A. Potential applications of carbomer in oral mucoadhesive controlled drug delivery system: a review. Drug Dev. Ind. Pharm. 2000; 26(9)913–924
- Perez‐Marcos B., Ford J. L., Armstrong D. J., Elliot P. N., Rostron C., Hogan J. E. Influence of pH on the release of propranolol hydrochloride from matrices containing hydroxyproylmethylcellulose K4M and Carbopol 974. J. Pharm. Sci. 1996; 85: 330–334
- Li S., Lin S., Daggy B. P., Mirchandani H. L., Chien Y. W. Effect of formulation variables on the floating properties of gastric floating drug delivery system. Drug Dev. Ind. Pharm. 2002; 28(7)783–793
- Bravo S. A., Lamas M. C., Salomon C. J. In‐vitro studies of diclofenac sodium controlled‐release from biopolymeric hydrophilic matrices. J. Pharm. Pharm. Sci. 2002; 5: 213–219
- Todd P. A., Sorkin E. M. Diclofenac sodium; a reappraisal of its pharmacodynamic and pharmacokinetics properties, and therapeutic efficacy. Drugs 1988; 35: 244–285
- Nokhodchi A., Farid Dj., Najafi M., Adrangui M. Studies on controlled release formulations of diclofenac sodium. Drug Dev. Ind. Pharm. 1997; 23(11)1019–1023
- Daravan S., Rashidi M. R., Hashemi M. Synthesis and characterization of methacrylic derivatives of 5‐amino salicylic acid with pH‐sensitive swelling properties. AAPS PharmSciTech 2001; 2(4), article 29
- Khan G. M., Jiabi Z. Formulation and in vitro evaluation of Ibuprofen–Carbopol® 974P‐NF controlled release matrix tablets III: influence of co‐excipients on release rate of the drug. J. Control. Release 1998; 54: 185–190
- Reynolds T. D., Gehrke S. H., Hussain A. S., Shenouda L. S. Polymer erosion and drug release of hydroxypropyl methylcellulose matrices. J. Pharm. Sci. 1998; 87: 1115–1123
- Shah N., Zhang G., Apelian V., Zeng F., Infeld M. H., Malick A. W. Prediction of drug release from hydroxypropylmethylcellulose (HPMC) matrices: effect of polymer concentration. Pharm. Res. 1993; 10: 1693–1695
- Madhusudan Rao Y., Krishna Veni J., Jayasagar G. Formulation and evaluation of diclofenac sodium using hydrophilic matrices. Drug Dev. Ind. Pharm. 2001; 27: 759–766
- Wotton P., Wade G., Moreton R. A. C. Cortwright, B. R. MathewsExcipients. International Product Registration: Aspect of Quality, Safety and Efficacy, . Ellis Horwood, London 1994; 148
- Gao P., Fagerness P. E. Determination of drug and water diffusivity in hydroxypropylmethylcellulose gels by pulsed‐field‐gradient spin echo NMR. Pharm. Res. 1993; 10: 1693–1695
- Gao P., Nixon P. R., Skoug J. W. Diffusion in HPMC gels. II. Prediction of drug release rates from hydrophilic matrix extended‐release dosage forms. Pharm. Res. 1995; 12: 965–971
- Samani S. M., Montaseri H., Kazemi A. The effect of polymer blends on release profiles of diclofenac sodium from matrices. Eur. J. Pharm. Biopharm. 2003; 55: 351–355